The FDA Just Approved The First US Freeze-Dried Plasma, Ready in Minutes
This could bring lifesaving transfusions far beyond hospitals.
The U.S. Food and Drug Administration has granted approval for Ezplaz Freeze Dried Plasma, marking a significant milestone as the nation’s first licensed freeze-dried plasma product. This development addresses a critical gap in emergency medicine by enabling rapid blood transfusions in settings where conventional plasma storage and preparation prove impractical.
Traditional plasma requires continuous freezing and must be thawed before use, making it challenging to transport and administer in ambulances, remote areas, disaster zones, and military settings. Ezplaz eliminates these complications through freeze-drying technology that allows the product to remain stable at room temperature for up to 12 months. Medical professionals can prepare the plasma for transfusion in approximately 2.5 minutes by simply adding sterile water from an included kit.
The product comes in blood group AB and group A variants specifically chosen to minimize dangerous incompatibility reactions when patient blood types remain unknown during emergencies. Healthcare providers intend to use Ezplaz for severe bleeding cases, massive transfusions, and patients requiring urgent reversal of blood thinner effects. The FDA’s approval was based on early safety data from 24 healthy volunteers, though the agency has required ongoing studies to monitor potential blood clot complications in actual patient populations.
While Ezplaz carries similar risks to conventional plasma transfusions, including allergic reactions and circulatory complications, regulators determined its benefits justify approval for limited emergency applications. The innovation potentially expands life-saving treatment availability beyond traditional hospital settings.
Originally reported by Sciencealert →
About the Author
